| ACF | Aberrant crypt foci |
| AGEs | Advanced glycation end products |
| Akt | Protein kinase B |
| AP-1 | Activator protein 1 |
| ATM | Ataxia telangiectasia mutated |
| DNA | Deoxyribonucleic acid |
| EGFR | Epidermal growth factor receptor |
| Erg-1 | Early growth response protein 1 |
| FoxO1 | Forkhead box protein O1 |
| GBM | Glioblastoma multiform |
| HIF-1 | Hypoxia-inducible factor 1 |
| HMEC | Human mammary epithelial cells |
| IKKα | IκB kinase α |
| IR | Ionizing radiation |
| JAK2 | Janus kinase 2 |
| MAPK | Mitogen activated protein kinase |
| NF-κB | Nuclear factor kappa B |
| NK | Natural killer cells |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| NSCLC | Non-small cell lung cancer |
| PD | Pharmacodynamic |
| PI3K | Phosphoinositide 3-kinase |
| PK | Pharmacokinetic |
| PPAR- α | Peroxisome proliferator-activated receptor alpha |
| ROS | Reactive oxygen species |
| RT | Radiotherapy |
| RV | Resveratrol |
| STAT3 | Transducer and activator of transcription 3 |
| TBK1 | TANK-binding kinase 1 |
| UA | Ursolic acid |
| VDR | Vitamin D receptor |
| VEGF | Vascular endothelial growth factor |
| WA | Withaferin A |
| WBC | White blood cells |
| ZER | Zingiber |